Mutations or deficiencies in myomesin can lead to various muscle disorders, including cardiomyopathies and myopathies. Understanding the role of myomesin in these conditions can help in developing targeted therapies and diagnostic tools. Research is ongoing to explore the potential of myomesin as a biomarker for muscle diseases.
